How to take niraparibabiraterone tablets correctly

Niraparib Abiraterone Tablets (Akeega) is a compound targeted drug for the treatment of metastatic castration-resistant prostate cancer . Its dosage regimen is complex and must be used strictly in accordance with professional guidance to ensure maximum efficacy and reduce adverse reactions. According to the current recommended regimen, the drug should be taken orally once a day at a dose of 200 mg of niraparib and 1000 mg of abiraterone acetate. At the same time, 10 mg of prednisone should be taken daily as an auxiliary hormone regulation drug to prevent the side effects of mineral corticosteroids caused by abiraterone acetate. It is recommended that the taking time be arranged in the early morning or at a fixed time period, and should be taken on an empty stomach. Avoid taking it at the same time with high-fat foods.

In addition to the drug itself, the basic conditions for treatment must also be met. All patients must be medically castrated, i.e. have undergone bilateral orchiectomy, or be receiving GnRH analog inhibitor treatment. This requirement ensures that testosterone levels in patients are maintained at a low level, creating basic conditions for abiraterone to fully exert its effect on inhibiting androgen production.

During the medication process, doctors should regularly check the patient's blood pressure, electrolytes (especially potassium), liver function, and blood routine to monitor drug-related toxicity. For patients who are older, have reduced hepatic and renal function, or have comorbid diseases, the starting dose may need to be adjusted individually. In addition, if the patient misses a dose while taking the medicine, he should take it as soon as possible on the same day and continue taking it as planned the next day; if vomiting occurs, it is recommended not to take the missed dose and continue taking the second dose on time.

At the same time, this program is usually used for HRR mutation-positive people. Doctors should evaluate whether the tumor has corresponding genetic characteristics before prescribing drugs, and stratify them appropriately to avoid unnecessary medication. During treatment, attention should also be paid to whether patients have early side effects such as fatigue, nausea, muscle weakness, etc., so that timely intervention can be provided.

In general, niraparib and abiraterone tablets have many medication details, but under the guidance of professional doctors, they can effectively control the disease. It is currently one of the few standard drugs in the field of prostate cancer that can be precisely treated through molecular classification.

Reference materials:https://www.drugs.com/akeega.html